Abstract PD13-10: Outcome of patritumab deruxtecan (HER3-DXd) in patients with HER2-positive metastatic breast cancer and CNS involvement previously treated with T-DXd: A subanalysis of TUXEDO-3
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: R. Bartsch, A. Llombart-Cussac, M. Gión, J. Garde-Noguera, R. Greil, M. Ruiz-Borrego, M. Valero, J. García-Mosquera, M. Arumi, J. Cortés, M. Campolier, J. Guerrero, J. Rodríguez-Morató, P. González-Alonso, I. Mas-Rincón, M. Vaz-Batista, M. Marhold, F. Oberndorfer, J. Furtner, T. Fuereder, A. Berghoff, M. Preusser
Institutions: Medical University of Vienna, Universidad Cardenal Herrera CEU, MedSIR (Spain), Hospital Arnau de Vilanova, Hospital Universitario Ramón y Cajal, Paracelsus Medical University, Hospital Universitario Virgen del Rocío, Hospital Quirónsalud Sagrado Corazón, Instituto Oncológico Dr. Rosell, IDCQ Hospitales y Sanidad, S.L.U., Vall d'Hebron Institute of Oncology, Hospital Universitario de Torrejón, Universidad Europea de Madrid, Danube Private University
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129351997
Cites:
Cited by:
Related to: